凯莱英(06821.HK)董事会批准使用不超过45亿元闲置自有资金购买短期理财产品

Core Viewpoint - Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd. has approved the use of idle self-owned funds to purchase financial products, indicating a strategic move to optimize asset management and enhance returns on available capital [1] Group 1 - The company will utilize an amount not exceeding 4.5 billion RMB (or equivalent foreign currency) for the purchase of short-term financial institution products [1] - The approval was made during the seventh meeting of the fifth board of directors held on March 13, 2026 [1] - The usage period for these funds is set within 12 months from the date of the board's approval, allowing for the funds to be recycled within the specified limit and timeframe [1]